Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07840534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU)

Study acronym: LYSA2PIFU
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fields
  2. Study First Submitted
Women treated for early-stage breast cancer commonly experience ongoing treatment-related symptoms while receiving adjuvant endocrine therapy. The LYSA2PIFU Trial will evaluate the feasibility and acceptability of a nurse-led Patient-Initiated Follow-Up (PIFU) model supported by electronic Patient-Reported Outcomes (ePROs), automated symptom-management resources, educational materials and symptom-triggered nurse consultations.
Trial Details
NCT Number NCT07840534
Lead Sponsor University College Cork
Collaborators: Cork University Hospital, Irish Cancer Society
Conditions
(from sponsor)		 Breast Cancer, Breast Cancer Survivorship, Cancer Survivorship, Endocrine Therapy, Early Stage Breast Cancer
Related terms Breast Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov